Category: Uncategorized

October 11, 2018 – Both leaders are passionate supporters of the Ontario life science sector, have broad industry experience and decades of work with entrepreneurial ventures.

September 13, 2018 – With an expanding portfolio of breakthrough innovations, FACIT is committed to supporting Ontario entrepreneurs through the latest round of its Prospects Oncology Fund.

June 27, 2018 – Derived from a leading oncology bio-computing group and leveraging insights from the world’s largest cancer genomics projects, Ziliomics develops web-based, modular software platforms that help physicians make actionable treatment decisions for patients living with cancer.

June 13, 2018 – Dr O’Neill brings two decades of cancer drug development and seed stage investment experience, as well as an extensive business network in pharma and biotech.

May 1, 2018 – FACIT looks forward to working with Dr. Radvanyi on translating Ontario’s breakthrough oncology innovations.

April 12, 2018 – Biotechnology competition modeled after popular TV program Dragons’ Den.

December 14, 2017 – We hope 2017 was a prosperous year for you, our partners in health innovation. While FACIT had many successes this year..

December 9, 2017 – Jeff was a fantastic leader in the OICR-FACIT family and the broader Ontario life sciences community.

December 6, 2017 – The Clinical Therapeutics Innovation Pipeline (CTIP) will support the local translation of Ontario discoveries into therapies with the potential for improving the lives of patients with cancer. Ten projects were selected in this highly competitive funding round, and reflect the strength of the province’s collaborative network and drug discoveries.

November 21, 2017 – New Trustees join existing Trustees, Mr. Greg Gubitz and Mr. John Morrison, bringing additional financial, entrepreneurial and biotech industry expertise.